Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Hong, Yanyan ^a   Li, Hongzhi ^a   Ye, Jingjing ^a   Miki, Yasuhiro ^b   Yuan, Yate Ching ^a   Sasano, Hironobu ^b   Evans, Dean B ^c   Chen, Shiuan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Novartis Institute for BioMedical Research Basel   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE; RECOMBINANT PROTEIN; TRYPSIN;

ANIMAL; ARTICLE; CARCINOMA; CELL MEMBRANE; CHEMISTRY; CHO CELL; CONFORMATION; CRICETULUS; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; HAMSTER; HUMAN; IMMUNOHISTOCHEMISTRY; KINETICS; METABOLISM; METHODOLOGY; NEOPLASM; STATIC ELECTRICITY;

ANIMALS; ANTIBODIES, MONOCLONAL; AROMATASE; CARCINOMA; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; ENDOPLASMIC RETICULUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; MOLECULAR CONFORMATION; NEOPLASMS; PEPTIDES; RECOMBINANT PROTEINS; STATIC ELECTRICITY; TRYPSIN;

EID: 77951231142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008050     Document Type: Article

References (30)

1. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, et al.(1992) Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 140: 337-343.
2. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER, (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77: 1622-1628.
3. James VH, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, et al.(1987) Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50: 269-279.
4. Bezwoda WR, Mansoor N, Dansey R, (1987) Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology 44: 345-349.
5. Miller WR, O'Neill J, (1987) The importance of local synthesis of estrogen within the breast. Steroids 50: 537-548.
6. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, et al.(1996) Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137: 3061-3068.
7. Sasano H, Harada N, (1998) Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 19: 593-607.
8. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M, (1994) Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Human pathology 25: 530-535.
9. Shenton KC, Dowsett M, Lu Q, Brodie A, Sasano H, et al.(1998) Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Res Treat 49 (Suppl 1): S101-107; discussion S109-119.
10. Sasano H, Anderson TJ, Silverberg SG, Santen RJ, Conway M, et al.(2005) The validation of new aromatase monoclonal antibodies for immunohistochemistry-a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol 95: 35-39.
11. Sasano H, Edwards DP, Anderson TJ, Silverberg SG, Evans DB, et al.(2003) Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J Steroid Biochem Mol Biol 86: 239-244.
12. Wang M, Roberts DL, Paschke R, Shea TM, Masters BS, et al.(1997) Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci U S A 94: 8411-8416.
13. Ghosh D, Griswold J, Erman M, Pangborn W, (2009) Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 457: 219-223.
14. Strobel HW, Nadler SG, Nelson DR, (1989) Cytochrome P-450: cytochrome P-450 reductase interactions. Drug Metab Rev 20: 519-533.
15. Nisimoto Y, (1986) Localization of cytochrome c-binding domain on NADPH-cytochrome P-450 reductase. J Biol Chem 261: 14232-14239.
16. Nadler SG, Strobel HW, (1988) Role of electrostatic interactions in the reaction of NADPH-cytochrome P-450 reductase with cytochromes P-450. Arch Biochem Biophys 261: 418-429.
17. Bernhardt R, Pommerening K, Ruckpaul K, (1987) Modification of carboxyl groups on NADPH-cytochrome P-450 reductase involved in binding of cytochromes c and P-450 LM2. Biochem Int 14: 823-832.
18. Turner KJ, Macpherson S, Millar MR, McNeilly AS, Williams K, et al.(2002) Development and validation of a new monoclonal antibody to mammalian aromatase. J Endocrinol 172: 21-30.
19. Bernhardt R, Kraft R, Otto A, Ruckpaul K, (1988) Electrostatic interactions between cytochrome P-450 LM2 and NADPH-cytochrome P-450 reductase. Biomed Biochim Acta 47: 581-592.
20. Shimizu T, Tateishi T, Hatano M, Fujii-Kuriyama Y, (1991) Probing the role of lysines and arginines in the catalytic function of cytochrome P450d by site-directed mutagenesis. Interaction with NADPH-cytochrome P450 reductase. J Biol Chem 266: 3372-3375.
21. Stayton PS, Sligar SG, (1990) The cytochrome P-450cam binding surface as defined by site-directed mutagenesis and electrostatic modeling. Biochemistry 29: 7381-7386.
22. Nelson DR, Strobel HW, (1988) On the membrane topology of vertebrate cytochrome P-450 proteins. J Biol Chem 263: 6038-6050.
23. Mintseris J, Pierce B, Wiehe K, Anderson R, Chen R, et al.(2007) Integrating statistical pair potentials into protein complex prediction. Proteins 69: 511-520.
24. Sevrioukova IF, Li H, Zhang H, Peterson JA, Poulos TL, (1999) Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A 96: 1863-1868.
25. Nadler SG, Strobel HW, (1991) Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450. Arch Biochem Biophys 290: 277-284.
26. Hong Y, Yu B, Sherman M, Yuan YC, Zhou D, et al.(2007) Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase. Mol Endocrinol 21: 401-414.
27. Shen AL, Porter TD, Wilson TE, Kasper CB, (1989) Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J Biol Chem 264: 7584-7589.
28. Hamdane D, Xia C, Im SC, Zhang H, Kim JJ, et al.(2009) Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450. J Biol Chem 284: 11374-11384.
29. Hong Y, Li H, Yuan YC, Chen S, (2009) Molecular characterization of aromatase. Ann N Y Acad Sci 1155: 112-120.
30. Zhou DJ, Pompon D, Chen S, (1990) Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res 50: 6949-6954.